» Authors » Timothy Starr

Timothy Starr

Explore the profile of Timothy Starr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 48
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao X, Starr T, Subramanian S
Cancers (Basel) . 2023 Aug; 15(16). PMID: 37627225
In recent years, cancer immunotherapy research has made remarkable progress, completely transforming the cancer treatment landscape [...].
2.
Scott P, Wang S, Onyeaghala G, Pankratz N, Starr T, Prizment A
Cancers (Basel) . 2023 Feb; 15(3). PMID: 36765944
Individuals with cystic fibrosis (CF), caused by biallelic germline mutations in the cystic fibrosis transmembrane conductance regulator (, have higher risk and earlier onset of colorectal cancer (CRC). A subset...
3.
Habicht J, Mooneyham A, Shetty M, Zhang X, Shridhar V, Winterhoff B, et al.
Cancer Biol Ther . 2019 Jul; 20(10):1304-1313. PMID: 31328624
UNC-45A is an ubiquitously expressed protein highly conserved throughout evolution. Most of what we currently know about UNC-45A pertains to its role as a regulator of the actomyosin system. However,...
4.
Hellweg R, Mooneyham A, Chang Z, Shetty M, Emmings E, Iizuka Y, et al.
Horm Cancer . 2018 Jun; 9(5):326-337. PMID: 29951943
Despite advances in surgical technique and adjuvant treatment, endometrial cancer has recently seen an increase in incidence and mortality in the USA. The majority of endometrial cancers can be cured...
5.
Iizuka Y, Mooneyham A, Sieben A, Chen K, Maile M, Hellweg R, et al.
Mol Biol Cell . 2017 Mar; 28(10):1337-1346. PMID: 28356421
UNC-45A is a highly conserved member of the UNC-45/CRO1/She4p family of proteins, which act as chaperones for conventional and nonconventional myosins. NMII mediates contractility and actin-based motility, which are fundamental...
6.
Park S, Kim S, Yu D, Pena-Llopis S, Gao J, Park J, et al.
Bioinformatics . 2015 Dec; 32(11):1643-51. PMID: 26635139
Motivation: Identification of altered pathways that are clinically relevant across human cancers is a key challenge in cancer genomics. Precise identification and understanding of these altered pathways may provide novel...
7.
Hwang T, Atluri G, Kuang R, Kumar V, Starr T, Silverstein K, et al.
BMC Genomics . 2013 Jul; 14:440. PMID: 23822816
Background: Many large-scale studies analyzed high-throughput genomic data to identify altered pathways essential to the development and progression of specific types of cancer. However, no previous study has been extended...